Sucrose concentration influences the rate of human oocytes with normal spindle and chromosome configurations after slow-cooling cryopreservation.
BACKGROUND
Recently described slow-cooling cryopreservation protocols involving elevated sucrose concentration have improved survival frequencies of human oocytes, potentially overcoming a major hurdle that has limited the adoption of oocyte storage. Because implantation rates of embryos from frozen oocytes remain generally low, it is still debated whether, irrespective of survival rates, this form of cryopreservation leads inevitably to the disruption or complete loss of the metaphase II (MII) spindle.


METHODS
Human oocytes with an extruded polar body I (PBI) were cryopreserved using a slow-cooling method including 1.5 mol/l propane-1,2-diol (PrOH) and alternative sucrose concentrations (either 0.1 or 0.3 mol/l) in the freezing solution. Fresh control and frozen-thawed survived oocytes were analysed by confocal microscopy to evaluate MII spindle and chromosome organizations.


RESULTS
Of the 104 oocytes included in the unfrozen group, 76 (73.1%) displayed normal bipolar spindles with equatorially aligned chromosomes. Spindle and chromatin organizations were significantly affected (50.8%) after cryopreservation involving lower sucrose concentration (61 oocytes), whereas these parameters were unchanged (69.7%) using the 0.3 mol/l sucrose protocol (152 oocytes).


CONCLUSIONS
Partial disruption of the MII spindle and associated chromosomes accompanies inadequate cryopreservation during slow cooling. However, protocols adopting higher sucrose concentration in the freezing solution promote the retention of an intact chromosome segregation apparatus comparable in incidence to freshly collected oocytes.
Tecnobios Procreazione, Bologna, Italy. coticchio@tecnobiosprocreazione.it
G
G
Coticchio
L
L
De Santis
G
G
Rossi
A
A
Borini
D
D
Albertini
G
G
Scaravelli
C
C
Alecci
V
V
Bianchi
S
S
Nottola
S
S
Cecconi
D002877:Chromosomes, Human / Q000648:ultrastructure*; D015925:Cryopreservation / Q000379:methods*; D005260:Female; D006801:Humans; D008938:Mitosis / Q000502:physiology; D009865:Oocytes / Q000187:drug effects* / Q000502:physiology / Q000648:ultrastructure; D008941:Spindle Apparatus / Q000648:ultrastructure; D013395:Sucrose / Q000008:administration & dosage / Q000494:pharmacology*
D013395:Sucrose